Kemnay Advisory Services’s Gilead Sciences GILD Stock Holding History

Kemnay Advisory Services’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$65.9K	Buy	522 +22	+4%	+$2.9K	0.01%	230
2026 Q1	$69.7K	Buy	500 +6	+1%	+$840	0.01%	188
2025 Q4	$60.6K	Buy	+494	New	+$60K	0.01%	273
2021 Q3	–	Sell	-11,669	Closed	-$804K	–	101
2021 Q2	$804K	Buy	+11,669	New	+$779K	0.1%	59

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kemnay Advisory Services's GILD Position: Q2 2026 in Review

Kemnay Advisory Services increased its Gilead Sciences (GILD) stake by 4.4% in Q2 2026, buying an estimated $2.9K and bringing the position to 522 shares worth $65.9K. The position accounts for 0.01% of the portfolio, ranked #230.

Kemnay Advisory Services first reported a position in GILD in Q2 2021 and has held it in 4 quarters since. The position peaked at $804K in Q2 2021. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Kemnay Advisory Services held 522 shares of Gilead Sciences worth $65.9K as of Q2 2026.
Kemnay Advisory Services bought 22 Gilead Sciences shares in Q2 2026, an estimated $2.9K.
Gilead Sciences made up 0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #230 holding.
Kemnay Advisory Services first reported a position in Gilead Sciences in Q2 2021 and has held it in 4 quarters since.
Kemnay Advisory Services's Gilead Sciences position peaked at $804K in Q2 2021.
2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.